Skip to main content
FinSpry Logo
FinSpry
KYMR logo
KYMR
(NASDAQ)
Kymera Therapeutics, Inc.
$80.65-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Kymera Therapeutics (KYMR) Stock Price & Financial Analysis

Kymera Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$78.41 - $81.42
52-Week High$103.00
52-Week Low$28.06
Open$78.59
Volume516.17K
Average Volume (3M)502.83K
Market Cap7.62B
Shares Outstanding97.53M
Price to Sales (P/S)148.06
Price to Book (P/B)4.95
EV/EBITDA-23.18
Revenue (TTM)51.48M
Net Income (TTM)-315.00M
Free Cash Flow (TTM)-244.00M
EPS (TTM)$-3.55
Profit Margin-611.96%
Operating Margin-690.19%
Return on Equity (ROE)-20.46%
Debt to Equity0.04
50-Day MA$83.56
200-Day MA$68.54
52-Week Change161.42%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Kymera Therapeutics

What is the current stock price for KYMR?

As of the latest trading session, KYMR stock trades at $80.65. The 52-week range is $28.06–$103.00, with a day range of $78.41–$81.42.

What is the P/E ratio for KYMR?

The P/E ratio (Price-to-Earnings) for KYMR is shown in the Key Statistics section. This valuation metric helps compare Kymera Therapeutics, Inc. to industry peers.

Does KYMR pay dividends?

Kymera Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KYMR?

Based on 6 analysts, the consensus for KYMR is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KYMR?

Kymera Therapeutics's market capitalization is $7.87B, classifying it as a mid-cap company. Kymera Therapeutics operates in the Healthcare sector within the Biotechnology industry.